Skip to main content

Table 4 Comparison between PsA patients and controls: change in bodyweight, BMI, CRP and urate at the 6-months (M6) and 12-months (M12) visits

From: Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up

 

Patients

N = 39

Controls

N = 39

p-value

M6

Weight loss since baseline. kg

19.0 (15.6–27.0)

23.0 (17.5–29.5)

0.280

Weight loss/baseline weight %

18.7 (15.2–26.7)

21.7 (15.5–26.4)

0.600

∆ BMI kg/m2

7.1 (5.3–9.6]

8.0 (6.3–10.7)

0.213

∆ CRP mg/L

1 (1–4)

2 (0–3)

0.562

∆ urate μmol/L

40 (−2.0–81.5)

40.5 (6.8–77.5)

0.954

M12

Weight loss since baseline, kg

16.1 (10.5–22.8)

16.6 (9.7–22.9)

0.885

Weight loss/baseline weight %

16.3 (10.5–22.4)

15.7 (9.8–21.2)

0.853

∆BMI kg/m2

5.7 (3.6–8.5)

6.0 (3.7–8.2)

0.657

∆ CRP mg/L

2 (0–4)

2 (0–3)

0.952

∆ urate μmol/L

28 (−6.5–68.5)

35.5 (−3.3–58.8)

0.775

  1. BMI = Body Mass Index, CRP = C- reactive protein